Biotech Values

[dewophile]

Not clear to me that Viekera will play well with amiodarone either because of the CYP3A4 issue

one last note - this is due to the ritonavir component, and this shouldn't affect the abbv second generation DAA combo, whereas all of GILD's second gen combos use sovaldi. This could also be a niche where MRK can win some market share if/when approved